Lympha Bio develops human microphysiological models of the lymph node to support immune-relevant drug development. Our platform is designed to help biotech and pharmaceutical teams better evaluate immunotoxicity, immune function, and therapeutic response using physiologically realistic, human-relevant systems.

Founded by scientists with over a decade of experience in lymphoid tissue modeling and immune analytics, Lympha Bio was created to address a critical gap between traditional in vitro assays and in vivo models. Our lymph node models preserve key features of lymphoid architecture and immune cell interactions, enabling more predictive insights earlier in development.

Lympha Bio currently offers its platform as a service, with initial applications in toxicology and planned expansion into vaccine and immunotherapy screening. We are proud to be supported by the Virginia Innovation Partnership Corporation (VIPC) and are actively engaging with partners interested in piloting studies or collaborating. 

Lympha Bio, Inc.

Org chart

Teams

Offices

Lympha Bio, Inc.

Org chart

Teams

Offices

Related companies